Lv1
18 积分 2022-12-15 加入
Safety and pharmacokinetics of SOR102, an oral bispecific inhibitor of TNF and interleukin-23 in healthy participants and patients with ulcerative colitis: a first-in-human, double-blind, randomised, placebo-controlled, phase 1 trial
27天前
已完结
Demonstration of a robust high cell density transient CHO platform yielding mAb titers of up to 2 g/L without medium exchange
3个月前
已完结
A transposon-based transient transfection system in CHO-K1 cells enables quality prediction of stable cell line proteins
3个月前
已完结
Multiplex genome editing eliminates lactate production without impacting growth rate in mammalian cells
5个月前
已完结
Tailoring Plasmid Design Based on Chain Expression in Cell Line Development for Enhanced Monoclonal and Bispecific Antibody Production
5个月前
已完结
Recombinant Antibody-Producing Stable CHOK1 Pool Stability Study
6个月前
已完结
皖公网安备34019202002308
